XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
Total share-based compensation expense was as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
(In thousands)
Stock option expense$3,417 $3,560 $10,443 $10,740 
Restricted stock expense5,106 5,578 15,232 15,875 
Performance restricted stock unit expense4,220 3,775 9,232 9,158 
Total pre-tax expense$12,743 $12,913 $34,907 $35,773 
Schedule of Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated:
Nine Months Ended
September 30, 2024
Year Ended December 31, 2023
Expected volatility28.2 %26.0 %
Expected term (years)5.05.0
Risk-free interest rate4.31 %3.54 %
Expected dividend yield0.62 %0.72 %
Black-Scholes-Merton fair value per stock option granted$56.42 $38.11 
Schedule of Stock Option Activity and Related Information
The following is a summary of the Company’s stock option activity and related information:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life 
Aggregate
Intrinsic
Value
(In thousands)(Years)(In millions)
Outstanding at December 31, 20232,741 $101.20 
Granted231 181.93 
Exercised(482)83.93 
Forfeited(44)149.47 
Outstanding at September 30, 20242,446 $111.35 6.4$149.8 
Exercisable at September 30, 20241,809 $96.89 5.7$135.4 
Schedule of Nonvested Restricted Stock Activity and Related Information
The following is a summary of the Company’s non-vested restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested restricted stock outstanding at December 31, 2023296 $135.39 
Granted148 181.60 
Vested(141)132.77 
Forfeited(22)153.79 
Non-vested restricted stock outstanding at September 30, 2024281 $159.52 
The following is a summary of the Company’s non-vested performance restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested performance restricted stock outstanding at December 31, 2023239 $131.90 
Granted77 181.93 
Performance assumption change 1
24 121.91 
Vested(99)121.91 
Forfeited(6)155.48 
Non-vested performance restricted stock outstanding at September 30, 2024235 $150.93 
_________________________________________
1 Reflects the number of PRSUs above target levels based on performance metrics.